Company data sheet · Masimo
Masimo: still smaller than it was.
- Industry
- Electromedical & Electrotherapeutic Apparatus Manufacturing
- Headquarters
- United States
- Sources
- SEC filings (1996–2026), Stratrix's verified Decision Cases, market data and official economic statistics for the United States
- Data as of
- October 18, 2026
- Still smaller than it was. Revenue reached $1.5 billion in fiscal 2026, 25% below its 2022 peak of $2 billion.
- Leaders came and went. Masimo filed 39 leadership changes since 2016, more than 93% of large manufacturers (the median is 19).
Financial results
| Fiscal year | Revenue | Net income | |
|---|---|---|---|
| 2016 | $0.6 billion | $0.1 billion | |
| 2016 | $0.7 billion | $0.3 billion | |
| 2017 | $0.8 billion | $0.1 billion | |
| 2018 | $0.9 billion | $0.2 billion | |
| 2019 | $0.9 billion | $0.2 billion | |
| 2021 | $1.1 billion | $0.2 billion | |
| 2022 | $1.2 billion | $0.2 billion | |
| 2022 | $2 billion | $0.1 billion | |
| 2023 | $1.3 billion | $0.1 billion | |
| 2024 | $1.4 billion | −$0.3 billion | |
| 2026 | $1.5 billion | −$0.2 billion |
As reported in its annual filings. Losses in red.
The full data sheet · Data Plan
Everything behind these findings, ready for your board deck.
- Market reaction to disclosed decisions: 65 decision filings since 2016, each linked to the SEC, with the share return against its sector and the S&P 500 the next day and the next year (0 with market data).
- Economic context: 7 measures for the United States, every year since 2016, from the official sources.
- Peer comparison: against 953 companies of its size in its sector.
- Financial results: ten years of revenue, operating and net income, and every annual report, linked.
- Methods and sources, so each number can be checked and cited.
The full data sheet downloads with the Data Plan. To see exactly what you get first, open the Boeing sample PDF or Excel.